The role of stent placement above the papilla (inside-stent) as a bridging therapy for perihilar biliary malignancy: an initial experience.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 22 08 2020
accepted: 21 02 2021
pubmed: 10 4 2021
medline: 30 12 2021
entrez: 9 4 2021
Statut: ppublish

Résumé

Although endoscopic naso-biliary drainage (ENBD) is a popular preoperative biliary drainage (PBD) method for patients with perihilar biliary malignancy (PHBM), patient discomfort caused by the nasal tube remains a problem. This study aimed to analyze the safety and efficacy of PBD with the placement of a plastic stent above the papilla [inside-stent (IS)] as a bridging therapy. The outcomes of 78 patients with potentially resectable PHBM, of whom 29 underwent IS placement and 49 underwent ENBD were evaluated. The stent-associated complication rates were not different between the two groups (7% in the IS group and 10% in the ENBD group, P = 0.621). Catheter dislocation occurred less frequently (0% vs. 22%, P = 0.016), and the median time to recurrent biliary obstruction was longer (not reached vs. 32 days, P = 0.039) in the IS group than in the ENBD group. Among the patients who underwent resection, their postoperative severe complication rates were not substantially different (26% vs. 25%, P = 0.923). IS placement is a possible alternative to ENBD as a bridge to a definitive operation for patients with resectable PHBM and a prospective trial to prove its feasibility and safety is therefore warranted.

Identifiants

pubmed: 33835263
doi: 10.1007/s00595-021-02268-8
pii: 10.1007/s00595-021-02268-8
doi:

Substances chimiques

Plastics 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1795-1804

Informations de copyright

© 2021. Springer Nature Singapore Pte Ltd.

Références

Nimura Y, Hayakawa N, Kamiya J, Kondo S, Shionoya S. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg. 1990;14(4):535–43 ((discussion 44)).
doi: 10.1007/BF01658686
Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T, Nagino M. The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies. Surgery. 2014;156(5):1190–6.
doi: 10.1016/j.surg.2014.04.036
Ribero D, Zimmitti G, Aloia TA, Shindoh J, Forchino F, Amisano M, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg. 2016;223(1):87–97.
doi: 10.1016/j.jamcollsurg.2016.01.060
Sakata J, Shirai Y, Tsuchiya Y, Wakai T, Nomura T, Hatakeyama K. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg. 2009;394(6):1065–72.
doi: 10.1007/s00423-009-0464-1
Cho JY, Han H-S, Yoon Y-S, Hwang DW, Jung K, Kim JH, et al. Preoperative cholangitis and metastatic lymph node have a negative impact on survival after resection of extrahepatic bile duct cancer. World J Surg. 2012;36(8):1842–7.
doi: 10.1007/s00268-012-1594-0
Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, et al. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobil Pancreat Surg. 2008;15(1):25–30.
doi: 10.1007/s00534-007-1277-7
Hameed A, Pang T, Chiou J, Pleass H, Lam V, Hollands M, et al. Percutaneous vs endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma—a systematic review and meta-analysis. Hpb. 2016;18(5):400–10.
doi: 10.1016/j.hpb.2016.03.002
Nakai Y, Yamamoto R, Matsuyama M, Sakai Y, Takayama Y, Ushio J, et al. Multicenter study of endoscopic preoperative biliary drainage for malignant hilar biliary obstruction: E-POD hilar study. J Gastroenterol Hepatol. 2018;33(5):1146–53.
doi: 10.1111/jgh.14050
Takahashi Y, Ito H, Inoue Y, Mise Y, Ono Y, Sato T, et al. Preoperative biliary drainage for patients with perihilar bile duct malignancy. J Gastrointest Surg. 2020;24(7):1630–8.
doi: 10.1007/s11605-019-04231-y
Coelen RJS, Roos E, Wiggers JK, Besselink MG, Buis CI, Busch ORC, et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(10):681–90.
doi: 10.1016/S2468-1253(18)30234-6
Takahashi Y, Nagino M, Nishio H, Ebata T, Igami T, Nimura Y. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma. Br J Surg. 2010;97(12):1860–6.
doi: 10.1002/bjs.7228
Komaya K, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, et al. Verification of the oncologic inferiority of percutaneous biliary drainage to endoscopic drainage: a propensity score matching analysis of resectable perihilar cholangiocarcinoma. Surgery. 2017;161(2):394–404.
doi: 10.1016/j.surg.2016.08.008
Kawakami H, Kuwatani M, Onodera M, Haba S, Eto K, Ehira N, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol. 2010;46(2):242–8.
doi: 10.1007/s00535-010-0298-1
Kawakubo K, Kawakami H, Kuwatani M, Haba S, Kudo T, Taya YA, et al. Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma. World J Gastrointest Endosc. 2016;8(9):385–90.
doi: 10.4253/wjge.v8.i9.385
Kawashima H, Itoh A, Ohno E, Itoh Y, Ebata T, Nagino M, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma. Ann Surg. 2013;257(1):121–7.
doi: 10.1097/SLA.0b013e318262b2e9
Chaudhary RJ, Higuchi R, Nagino M, Unno M, Ohtsuka M, Endo I, et al. Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,778 cases. J Hepatobil Pancreat Sci. 2019;26(11):490–502.
doi: 10.1002/jhbp.668
Maeda T, Ebata T, Yokoyama Y, Mizuno T, Yamaguchi J, Onoe S, et al. Preoperative course of patients undergoing endoscopic nasobiliary drainage during the management of resectable perihilar cholangiocarcinoma. J Hepatobil Pancreat Sci. 2019;26(8):341–7.
Jo JH, Chung MJ, Han DH, Park JY, Bang S, Park SW, et al. Best options for preoperative biliary drainage in patients with Klatskin tumors. Surg Endosc. 2016;31(1):422–9.
doi: 10.1007/s00464-016-4993-8
Pedersen FM, Lassen AT, de Muckadell OBS. Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc. 1998;48(6):574–9.
doi: 10.1016/S0016-5107(98)70038-0
Liu Q, Khay G, Cotton PB. Feasibility of stent placement above the sphincter of Oddi (“inside-stent”) for patients with malignant biliary obstruction. Endoscopy. 1998;30(8):687–90.
doi: 10.1055/s-2007-1001389
Yazumi S, Yoshimoto T, Hisatsune H, Hasegawa K, Kida M, Tada S, et al. Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. J Hepatobil Pancreat Surg. 2006;13(6):502–10.
doi: 10.1007/s00534-005-1084-y
Tsujino T, Isayama H, Sugawara Y, Sasaki T, Kogure H, Nakai Y, et al. Endoscopic management of biliary complications after adult living donor liver transplantation. Am J Gastroenterol. 2006;101(10):2230–6.
doi: 10.1111/j.1572-0241.2006.00797.x
Kurita A, Kodama Y, Minami R, Sakuma Y, Kuriyama K, Tanabe W, et al. Endoscopic stent placement above the intact sphincter of Oddi for biliary strictures after living donor liver transplantation. J Gastroenterol. 2013;48(9):1097–104.
doi: 10.1007/s00535-012-0705-x
Uchida N, Tsutsui K, Ezaki T, Fukuma H, Kamata H, Kobara H, et al. Estimation of the stent placement above the intact sphincter of Oddi against malignant bile duct obstruction. J Gastroenterol. 2005;40(3):291–6.
doi: 10.1007/s00535-004-1535-2
Ishiwatari H, Hayashi T, Ono M, Sato T, Kato J. Newly designed plastic stent for endoscopic placement above the sphincter of Oddi in patients with malignant hilar biliary obstruction. Dig Endosc. 2013;25(Suppl 2):94–9.
doi: 10.1111/den.12080
Inatomi O, Bamba S, Shioya M, Mochizuki Y, Ban H, Tsujikawa T, et al. Threaded biliary inside stents are a safe and effective therapeutic option in cases of malignant hilar obstruction. BMC Gastroenterol. 2013;13:31.
doi: 10.1186/1471-230X-13-31
Kobayashi N, Watanabe S, Hosono K, Kubota K, Nakajima A, Kaneko T, et al. Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol. 2015;15(8).
Kubota K, Hasegawa S, Iwasaki A, Sato T, Fujita Y, Hosono K, et al. Stent placement above the sphincter of Oddi permits implementation of neoadjuvant chemotherapy in patients with initially unresectable Klatskin tumor. Endosc Int Open. 2016;04(04):E427–33.
doi: 10.1055/s-0042-102246
Isayama H, Hamada T, Yasuda I, Itoi T, Ryozawa S, Nakai Y, et al. TOKYO criteria 2014 for transpapillary biliary stenting. Dig Endosc. 2015;27(2):259–64.
doi: 10.1111/den.12379
Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–93.
doi: 10.1016/S0016-5107(91)70740-2
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606–8.
doi: 10.2307/30148464
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 2019. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250–78 ((quiz 79–80)).
doi: 10.1086/501620
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240(2):205–13.
doi: 10.1097/01.sla.0000133083.54934.ae
Mise Y, Vauthey J-N, Zimmitti G, Parker NH, Conrad C, Aloia TA, et al. Ninety-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality. Ann Surg. 2015;262(6):1071–8.
doi: 10.1097/SLA.0000000000001048
Wiggers J, Koerkamp B, Coelen R, Rauws E, Schattner M, Nio C, et al. Preoperative biliary drainage in perihilar cholangiocarcinoma: identifying patients who require percutaneous drainage after failed endoscopic drainage. Endoscopy. 2015;47(12):1124–31.
doi: 10.1055/s-0034-1392559

Auteurs

Yu Takahashi (Y)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. yu.takahashi@jfcr.or.jp.

Naoki Sasahira (N)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Takashi Sasaki (T)

Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Yosuke Inoue (Y)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Yoshihiro Mise (Y)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Takafumi Sato (T)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Yoshihiro Ono (Y)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Atsushi Oba (A)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Akio Saiura (A)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Hiromichi Ito (H)

Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH